Assystem acquires controlling stake in The Biotech Quality Group

Assystem acquired a 72.7% interest in The Biotech Quality Group, a Belgian consulting firm specializing in regulatory compliance for the pharmaceutical and biotech industries.

“The combined skills and expertise of BQG and Assystem will enable us to propose to the market a unique offering encompassing quality, regulatory compliance and performance at all stages of a drug's life cycle.”globenewswire.com

• 1 source
• globenewswire.comASSYSTEM: Reinforces its positions in the Life SciencesASSYSTEMDec 5, 2017

Summarized from public sources; check the original articles before acting on it.